Login to Your Account

Financings Roundup

Immunomedics Seeks $14M as Bridge to Milestones

By Marie Powers
Staff Writer

Monday, February 25, 2013
Immunomedics Inc. went small with its first financing in more than five years, pricing an underwritten public offering of 6.1 million shares at $2.30 each – a 15 percent discount to Thursday's closing price – and seeking to raise just $14 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription